J Appl Biomed 17:33, 2019 | DOI: 10.32725/jab.2018.002

Selected rare paediatric communication neurological disorders

Blanka Klimova1, Martin Valis1, Jakub Hort2,3, Kamil Kuca4,5,*
1 University Hospital Hradec Kralove, Department of Neurology, Hradec Kralove, Czech Republic
2 Charles University in Prague, 2nd Faculty of Medicine and University Hospital Motol, Memory Disorders Clinic, Department of Neurology, Prague, Czech Republic
3 St. Anne's University Hospital Brno, International Clinical Research Center, Brno, Czech Republic
4 University of Hradec Kralove, Faculty of Science, Department of Chemistry, Hradec Kralove, Czech Republic
5 University Hospital Hradec Kralove, Biomedical Research Centre, Hradec Kralove, Czech Republic

The purpose of this review is to discuss rare neurological disorders with respect to communication difficulties typical of children. Firstly, communication disorders with special focus on rare communication neurological disorders are discussed. Secondly, on the basis of literature review, the authors explore clinical studies on the most typical rare children's communication neurological disorders. Thirdly, on the basis of the findings from the clinical studies, they set a few recommendations for their medical therapies and management. The methodology was based on the literature review of research studies exploring the research issue. The findings show that the intervention strategies appear to have positive effects on the improvement of speech and language production among children suffering from Landau-Kleffner syndrome and childhood apraxia of speech. Nevertheless, randomized control trials are needed in order to accelerate and facilitate an early and relevant diagnosis and treatment management. In addition, a multidisciplinary approach seems to be the most appropriate for the accurate diagnosis and comprehensive treatment.

Keywords: Childhood apraxia of speech; Communication; Landau-Kleffner syndrome; Language; Neurological disorders; Treatment
Grants and funding:

This work was supported by MH CZ – DRO (UHHK 00179906), PROGRES Q40 run at the Medical Faculty Charles University, and by the long-term development plan UHK.

Conflicts of interest:

The authors have no conflicts of interests to declare.

Received: March 20, 2018; Accepted: September 24, 2018; Prepublished online: November 23, 2018; Published: March 19, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klimova B, Valis M, Hort J, Kuca K. Selected rare paediatric communication neurological disorders. J Appl Biomed. 2019;17(1):33. doi: 10.32725/jab.2018.002. PubMed PMID: 34907755.
Download citation

References

  1. Aime S, Bellet B, Rath A (2015). Rare diseases in ICD 11: Making rare diseases visible in health information systems through appropriate coding. Orphanet J Rare Dis 10, 35. DOI: 10.1186/s13023-015-0251-8. Go to original source... Go to PubMed...
  2. ASHA (1982). Definitions-communicative disorders and variations. American Speech-Language-Hearing Association. 24(11): 949-950.
  3. ASHA (2017). Childhood apraxia of speech. [online] [cit. 2017-12-20]. Available from: http://www.asha.org/PRPSpecificTopic.aspx?folderid=8589935338§ion=Treatment.
  4. Beathard B, Krout RE (2008). A music therapy clinical case study of a girl with childhood apraxia of speech. The Arts in Psychotherapy. 35(2): 107-116. DOI: 10.1016/j.aip.2008.01.004. Go to original source...
  5. Campbell TF (2003). Childhood apraxia of speech: Clinical symptoms and speech characteristics. In: Shriberg LD, Campbell TF (Eds). Proceedings of the 2002 Childhood Apraxia of Speech Symposium. The Hendrix Foundation, Carlsbad, pp. 37-40.
  6. Dale PS, Hayden DA (2013). Treating speech subsystems in childhood apraxia of speech with tactual input: the PROMPT approach. Am J Speech Lang Pathol 22(4): 644-666. DOI: 10.1044/1058-0360(2013/12-0055). Go to original source... Go to PubMed...
  7. Dodel R, Peter H, Walbert T, Spottke A, Noelker C, Berger K, et al. (2004). The socioeconomic impact of narcolepsy. Sleep 27(6): 1123-1128. Go to original source... Go to PubMed...
  8. European Commission on Public Health (2017). Useful information on rare diseases from an EU perspective. [online] [cit. 2017-12-20]. Available from: http://ec.europa.eu/health/ph_information/documents/ev20040705_rd05_en.pdf
  9. Fandino M, Connoly M, Usher L, Palm S, Kosak FK (2011). Landau/Kleffner syndrome: a rare auditory processing disorder series of cases and review of the literature. Int J Pediatr Otorhinolaryngol 75: 33-38. DOI: 10.1016/j.ijporl.2010.10.001. Go to original source... Go to PubMed...
  10. Federico A (2013). Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective). Rev Neurol 169(Suppl. 1): S12-S17. DOI: 10.1016/S0035-3787(13)70054-7. Go to original source... Go to PubMed...
  11. Guevara-Campos J, González-de Guevara L (2007). Landau-Kleffner syndrome: an analysis of 10 cases in Venezuela. Rev Neurol 44(11): 652-656. Go to original source...
  12. Hession CE, Eastwood B, Watterson D, Lehane CM, Oxley N, Murphy BA (2014). Therapeutic horse riding improves cognition, mood arousal, and ambulation in children with dyspraxia. J Altern Complement Med 20(1): 19-23. DOI: 10.1089/acm.2013.0207. Go to original source... Go to PubMed...
  13. Kleffner FR, Landau WM (2009). The Landau-Kleffner syndrome. Epilepsia 50(Suppl. 7): 4. Go to original source... Go to PubMed...
  14. Klimova B, Kuca K (2016a). Speech and language impairments in dementia - a mini-review. J Appl Biomed 14(2): 97-103. DOI: 10.1016/j.jab.2016.02.002. Go to original source...
  15. Klimova B, Kuca K (2016b). Multi-nutrient dietary intervention approach to the management of Alzheimer's disease - a mini-review. Curr Alzheimer Res 13(12): 1312-1318. Go to original source... Go to PubMed...
  16. Klimova B, Maresova P, Valis M, Hort J, Kuca K (2015). Alzheimer's disease and language impairments: Social intervention and medical treatment. Clin Interv Aging 10: 1401-1408. DOI: 10.2147/CIA.S89714. Go to original source... Go to PubMed...
  17. Kossoff EH, Los JG, Boatman DF (2007). A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy. Epilepsy Behav 11(4): 514-517. DOI: 10.1016/j.yebeh.2007.07.011. Go to original source... Go to PubMed...
  18. Krapp KM (2002). The Gale Encyclopedia of Nursing & Allied Health. 6th edition. Gale Group, Detroit.
  19. Kubackova K, et al. (2014). Vzacna onemocneni v kostce. [Rare Diseases in a Nutshell.] Mlada fronta, a. s., Praha (Czech).
  20. Lewis BA, Freebairn LA, Hansen A, Taylor HG, Iyengar SK, Shriberg LD (2004). Family pedigrees of children with suspected childhood apraxia of speech. J Commun Disord 37: 157-175. DOI: 10.1016/j.jcomdis.2003.08.003. Go to original source... Go to PubMed...
  21. Li Z, Gao Z, Jin C, Guo Q, Wang L, Shandan W, et al. (2014). The efficacy of leviteracetam versus carbamazepine for epilepsy: a meta-analysis. Iran J Public Health 43(12): 1616-1626.
  22. Longe JL (2011). The Gale Encyclopedia of Children's Health: Infancy through Adolescence. 2nd ed. Gale Group, Detroit.
  23. Lotte N (2006). The pathophysiological mechanisms of cognitive and behavioral disturbances in children with Landau-Kleffner syndrome or epilepsy with continuous spike-and-waves during slow-wave sleep. Seizure 15: 249-258. DOI: 10.1016/j.seizure.2006.02.008. Go to original source... Go to PubMed...
  24. Ludlow CL (2011). Spasmodic dysphonia: a laryngeal control disorder specific to speech. The J Neurosci 31(3): 793-797. DOI: 10.1523/JNEUROSCI.2758-10.2011. Go to original source... Go to PubMed...
  25. Maas E, Butalla CE, Farinella KA (2012). Feedback frequency in treatment for childhood apraxia of speech. Am J Speech Lang Pathol 21(3): 239-257. DOI: 10.1044/1058-0360(2012/11-0119). Go to original source... Go to PubMed...
  26. Maas E, Farinella KA (2012). Random versus blocked practice in treatment for childhood apraxia of speech. J Speech Lang Hear Res 55(2): 561-578. DOI: 10.1044/1092-4388(2011/11-0120). Go to original source... Go to PubMed...
  27. Maresova P, Klimova B, Kuca K (2016). Financial and legislative aspects of drug development of orphan diseases on the European market - a systematic review. Applied Economics 48(27): 2562-2570. DOI: 10.1080/00036846.2015.1125433. Go to original source...
  28. Marien P, Verhoeven J (2007). Cerebellar involvement in motor speech planning: some further evidence from foreign accent syndrome. Folia Phoniatr Logop 59(4): 210-217. DOI: 10.1159/000102933. Go to original source... Go to PubMed...
  29. Melby-Lervåg M, Hulme C (2013). Is working memory training effective? A meta-analytic review. Dev Psychol 49(2): 270-291. DOI: 10.1037/a0028228. Go to original source... Go to PubMed...
  30. Melby-Lervåg M, Hulme C (2016). There is no convincing evidence that working memory training is effective: A reply to Au et al. (2014) and Karbach and Verhaeghen (2014). Psychon Bull Rev 23(1): 324-330. DOI: 10.3758/s13423-015-0862-z. Go to original source... Go to PubMed...
  31. Mikati MA, Shamseddine AN (2005). Management of Landau-Kleffner syndrome. Paediatr Drugs 7(6): 377-389. Go to original source... Go to PubMed...
  32. Murray E, McCabe P, Ballard KJ (2012). A comparison of two treatments for childhood apraxia of speech: methods and treatment protocol for a parallel group randomized control study. BMC Pediatr 12: 112. DOI: 10.1186/1471-2431-12-112. Go to original source... Go to PubMed...
  33. Murray E, McCabe P, Ballard KJ (2014). A systematic review of treatment outcomes for children with childhood apraxia of speech. Am J Speech Lang Pathol 23(3): 486-504. DOI: 10.1044/2014_AJSLP-13-0035. Go to original source... Go to PubMed...
  34. Orphanet (2009). Jacobsen syndrome. [online] [cit. 2017-12-20]. Available from: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=2308
  35. Preston JL, Brick N, Landi N (2013). Ultrasound biofeedback treatment for persisting childhood apraxia of speech. Am J Speech Lang Pathol 22(4): 627-643. DOI: 10.1044/1058-0360(2013/12-0139). Go to original source... Go to PubMed...
  36. Rare Diseases Act of 2002 (2002). [online] [cit. 2017-12-20]. Available from: https://www.gpo.gov/fdsys/pkg/PLAW-107publ280/html/PLAW-107publ280.htm
  37. Sinclair DB, Snyder TJ (2005). Corticosteroids for the treatment of Landau-Kleffner syndrome and continuous spike-wave discharge during sleep. Pediatr Neurol 32(5): 300-306. DOI: 10.1016/j.pediatrneurol.2004.12.006. Go to original source... Go to PubMed...
  38. Thomas DC, McCabe P, Ballard KJ (2014). Rapid Syllable Transitions (ReST) treatment for childhood apraxia of speech: the effect of lower dose-frequency. J Commun Disord 51: 29-42. DOI: 10.1016/j.jcomdis.2014.06.004. Go to original source... Go to PubMed...
  39. Tisch SHD, Brake HM, Law M, Cole IE, Darveniza P (2003). Spasmodic dysphonia: clinical features and effects of botulinium toxin therapy in 169 patients - an Australian experience. J Clin Neurosci 10(4): 434-438. Go to original source... Go to PubMed...
  40. Velleman SL (2003). Childhood apraxia of speech: Resource guide. Thomson, New York.
  41. Winter J (2008). Critical review: evidence of the presence of literacy difficulties in children who have childhood apraxia of speech. [online] [cit. 2017-12-20]. Available from: https://www.uwo.ca/fhs/lwm/ebp/reviews/2007-08/Winter,MJ.pdf

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.